Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria L Garcia

Showing results (101-110 of 122) with videos related to

Pageof 13
Sort By:
Biochemistry|June 12, 2002
Identification of a new class of inhibitors of the voltage-gated potassium channel, Kv1.3, with immunosuppressant propertiesWilliam A Schmalhofer, Jianming Bao, Owen B McManus, et al.
The Lancet. Child & Adolescent Health|January 12, 2023
Efficacy of nirsevimab against respiratory syncytial virus lower respiratory tract infections in preterm and term infants, and pharmacokinetic extrapolation to infants with congenital heart disease and chronic lung disease: a pooled analysis of randomised controlled trialsEric A F Simões, Shabir A Madhi, William J Muller, et al.
Bioorganic & Medicinal Chemistry Letters|February 5, 2008
Imidazopyridines: a novel class of hNav1.7 channel blockersClare London, Scott B Hoyt, William H Parsons, et al.
Diabetes|March 29, 2006
Blockers of the delayed-rectifier potassium current in pancreatic beta-cells enhance glucose-dependent insulin secretionJames Herrington, Yun-Ping Zhou, Randal M Bugianesi, et al.
Bioorganic & Medicinal Chemistry Letters|June 26, 2007
Discovery of a novel class of benzazepinone Na(v)1.7 blockers: potential treatments for neuropathic painScott B Hoyt, Clare London, David Gorin, et al.
The Journal of Clinical Investigation|May 15, 2023
Cardiac pericytes mediate the remodeling response to myocardial infarctionPearl Quijada, Shuin Park, Peng Zhao, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 20, 2016
The Renal Outer Medullary Potassium Channel Inhibitor, MK-7145, Lowers Blood Pressure, and Manifests Features of Bartter's Syndrome Type II PhenotypeCaryn Hampton, Xiaoyan Zhou, Birgit T Priest, et al.
Bioorganic & Medicinal Chemistry Letters|October 1, 2013
Discovery of a novel sub-class of ROMK channel inhibitors typified by 5-(2-(4-(2-(4-(1H-Tetrazol-1-yl)phenyl)acetyl)piperazin-1-yl)ethyl)isobenzofuran-1(3H)-oneHaifeng Tang, Reynald K de Jesus, Shawn P Walsh, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of Selective Small Molecule ROMK Inhibitors as Potential New Mechanism DiureticsHaifeng Tang, Shawn P Walsh, Yan Yan, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Improved Cav2.2 Channel Inhibitors through a gem-Dimethylsulfone Bioisostere Replacement of a Labile SulfonamidePengcheng P Shao, Feng Ye, Prasun K Chakravarty, et al.
Pageof 13

Showing results (101-110 of 122) with videos related to

Sort By:
Pageof 13
Biochemistry|June 12, 2002
Identification of a new class of inhibitors of the voltage-gated potassium channel, Kv1.3, with immunosuppressant propertiesWilliam A Schmalhofer, Jianming Bao, Owen B McManus, et al.
The Lancet. Child & Adolescent Health|January 12, 2023
Efficacy of nirsevimab against respiratory syncytial virus lower respiratory tract infections in preterm and term infants, and pharmacokinetic extrapolation to infants with congenital heart disease and chronic lung disease: a pooled analysis of randomised controlled trialsEric A F Simões, Shabir A Madhi, William J Muller, et al.
Bioorganic & Medicinal Chemistry Letters|February 5, 2008
Imidazopyridines: a novel class of hNav1.7 channel blockersClare London, Scott B Hoyt, William H Parsons, et al.
Diabetes|March 29, 2006
Blockers of the delayed-rectifier potassium current in pancreatic beta-cells enhance glucose-dependent insulin secretionJames Herrington, Yun-Ping Zhou, Randal M Bugianesi, et al.
Bioorganic & Medicinal Chemistry Letters|June 26, 2007
Discovery of a novel class of benzazepinone Na(v)1.7 blockers: potential treatments for neuropathic painScott B Hoyt, Clare London, David Gorin, et al.
The Journal of Clinical Investigation|May 15, 2023
Cardiac pericytes mediate the remodeling response to myocardial infarctionPearl Quijada, Shuin Park, Peng Zhao, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 20, 2016
The Renal Outer Medullary Potassium Channel Inhibitor, MK-7145, Lowers Blood Pressure, and Manifests Features of Bartter's Syndrome Type II PhenotypeCaryn Hampton, Xiaoyan Zhou, Birgit T Priest, et al.
Bioorganic & Medicinal Chemistry Letters|October 1, 2013
Discovery of a novel sub-class of ROMK channel inhibitors typified by 5-(2-(4-(2-(4-(1H-Tetrazol-1-yl)phenyl)acetyl)piperazin-1-yl)ethyl)isobenzofuran-1(3H)-oneHaifeng Tang, Reynald K de Jesus, Shawn P Walsh, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of Selective Small Molecule ROMK Inhibitors as Potential New Mechanism DiureticsHaifeng Tang, Shawn P Walsh, Yan Yan, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Improved Cav2.2 Channel Inhibitors through a gem-Dimethylsulfone Bioisostere Replacement of a Labile SulfonamidePengcheng P Shao, Feng Ye, Prasun K Chakravarty, et al.
Pageof 13